GenAssist Inc.
GenAssist Inc. develops innovative biomaterials aimed at regenerating muscle tissue, particularly for patients suffering from traumatic muscle injuries. Their flagship technology, MyoMatrix™, is designed to support and heal muscle wounds caused by high-impact trauma, disease, and other injuries, with the potential to significantly improve recovery outcomes and reduce disability.
GenAssist Inc.
What We Do
MyoMatrix™
A patented scaffold technology made of natural extracellular matrix proteins designed to support and heal damaged muscle tissue. In preclinical studies, it has shown to increase muscle strength significantly post-implantation.
MyoSponge™
An implantable, sponge-like scaffold utilizing MyoMatrix™ technology, engineered to provide mechanical support to wounded areas and reinforce skeletal muscle tissue after severe trauma.
MyoGel™
An injectable formulation of MyoMatrix™ that remains gel-like at body temperature, allowing for minimally invasive applications in various conditions, including pelvic floor disorders and athletic injuries.
Key People
News & Updates
Joe Beggs delivers pitch at the BioHealth Capital Region Investment Conference in Rockville, MD
One of Ten innovative life sciences and healthtech companies chosen for 16-week accelerator
Gabe Haas delivers pitch to a room full of investors, strategic partners, and St. Louis ecosystem leaders
Team completes an additional 100+ customer interviews, bringing the total to over 200
Includes an equity-free investment of up to $50,000
Won a $20,000 of in-kind services from Hologic